Indian Journal of Ophthalmology
Clinical outcomes of slow-coagulation continuous wave diode transscleral cyclophotocoagulation laser for treatment of refractory glaucoma
By Vijayalakshmi A Senthilkumar, Sabari Jagadesh, Mary Anto and 2 others.
Abstract
Purpose
To evaluate the short-term safety and efficacy of slow-coagulation trans-scleral cyclophotocoagulation (SC-TSCPC) in patients with refractory glaucoma.
Methods
A retrospective study was done on 140 patients (144 eyes) with a diagnosis of refractory glaucoma and vision more than 2/60 with a minimum follow-up of 6 months. All patients underwent SC-TSCPC (800-milliwatt power and 4 seconds duration). The primary outcome measure was surgical success defined as an intraocular pressure (IOP) from 6 to 21 mmHg or ≥20% IOP reduction from the baseline value, no reoperation for glaucoma, and no loss of light perception vision. Secondary outcome measures include percentage of IOP reduction, glaucoma medications, visual acuity, and complications.
